Geographic Atrophy

Study highlights risks of macular neovascularization in patients treated for geographic atrophy

Patients who develop macular neovascularization (MNV) while undergoing intravitreal avacincaptad pegol (IVA) treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD) experience worse clinical outcomes, including greater vision loss and faster lesion growth, even with subsequent anti-VEGF therapy, according to a study. The study included 56 patients divided...